Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

Excedrin Migraine 2's- 25 Ct

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0270-2026
Class II · Moderate risk

Excedrin 2's Disp.- 30 Ct

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0269-2026
Class II · Moderate risk

LIQUID DAYQUIL 12/8oz

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0268-2026
Class II · Moderate risk

Dayquil Cold & Flu

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0267-2026
Class II · Moderate risk

Claritin

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0266-2026
Class II · Moderate risk

Bayer 2Pk- 25 CT

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0265-2026
Class II · Moderate risk

Benadryl

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0264-2026
Class II · Moderate risk

Alka Seltzer

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0263-2026
Class II · Moderate risk

Aleve 1's

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0262-2026
Class II · Moderate risk

Advil a) Ibuprofen

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Ongoing cGMP deviation Gold Star Distribution INC D-0261-2026
Class II · Moderate risk

Nivagen

cGMP deviations

Ongoing cGMP deviation Blossom Pharmaceuticals NDC 75834-170-02 D-0209-2026
Class II · Moderate risk

Nivagen

cGMP deviations

Ongoing cGMP deviation Blossom Pharmaceuticals NDC 75834-170-01 D-0208-2026
Class II · Moderate risk

Dynashield

cGMP deviations

Ongoing cGMP deviation Blossom Pharmaceuticals NDC 67777-407-03 D-0207-2026
Class II · Moderate risk

WeCare

cGMP deviations

Ongoing cGMP deviation Blossom Pharmaceuticals NDC 67777-223-05 D-0205-2026
Class II · Moderate risk

Dynagel

cGMP deviations

Ongoing cGMP deviation Blossom Pharmaceuticals D-0204-2026
Class II · Moderate risk

Wecare Enema

cGMP deviations

Ongoing cGMP deviation Blossom Pharmaceuticals NDC 67777-402-01 D-0203-2026